BLOCK LISTING APPLICATION

Dundee, Scotland, 27 August 2009: Axis-Shield plc (LSE: ASD, OSE: ASD): the international in vitro diagnostics company, today announces that application has been made to the UK Listing Authority and the London Stock Exchange for a block listing for 600,000 ordinary shares of 35p (thirty-five pence) each. This application is in respect of share issues as required in respect of option exercises under the Group's Medium Term Share Option Schemes.

This announcement is made on the London Stock Exchange and is repeated in Norway for Oslo Stock Exchange purposes under the 'equivalent information' rule (DTR Rule 2.4.).

Enquiries:

Axis-Shield plc                                                 Tel: +44 (0)203 178 7849
Ronny Hermansen, Finance Director

Notes to Editors:

About Axis-Shield
Axis-Shield is an international in vitro diagnostics company, headquartered in Dundee with R&D and manufacturing bases in Dundee and Oslo. The Group specialises in the supply of instruments and tests for the rapidly growing physician's office testing market and the development, manufacture and marketing of innovative proprietary diagnostics kits in areas of clinical need, including cardiovascular and neurological diseases, rheumatoid arthritis, and diabetes.

For more information on Axis-Shield,  please refer to www.axis-shield.com